Differential gene expression at the maternal-fetal interface in preeclampsia is influenced by gestational age

PLoS One. 2013 Jul 31;8(7):e69848. doi: 10.1371/journal.pone.0069848. Print 2013.

Abstract

Genome-wide transcription data of utero-placental tissue has been used to identify altered gene expression associated with preeclampsia (PE). As many women with PE deliver preterm, there is often a difference in gestational age between PE women and healthy pregnant controls. This may pose a potential bias since gestational age has been shown to dramatically influence gene expression in utero-placental tissue. By pooling data from three genome-wide transcription studies of the maternal-fetal interface, we have evaluated the relative effect of gestational age and PE on gene expression. A total of 18,180 transcripts were evaluated in 49 PE cases and 105 controls, with gestational age ranging from week 14 to 42. A total of 22 transcripts were associated with PE, whereas 92 transcripts with gestational age (nominal P value <1.51*10(-6), Bonferroni adjusted P value <0.05). Our results indicate that gestational age has a great influence on gene expression both in normal and PE-complicated pregnancies. This effect might introduce serious bias in data analyses and needs to be carefully assessed in future genome-wide transcription studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Gene Expression Regulation, Developmental*
  • Genome-Wide Association Study
  • Gestational Age
  • Humans
  • Linear Models
  • Maternal-Fetal Exchange / genetics
  • Oligonucleotide Array Sequence Analysis
  • Placenta / metabolism*
  • Pre-Eclampsia / genetics*
  • Pre-Eclampsia / physiopathology
  • Pregnancy
  • Pregnancy Trimester, Second
  • Pregnancy Trimester, Third
  • Transcriptome*

Grants and funding

This work was supported by grants from Functional genomics (FUGE) in Norway within the Research Council of Norway (Å.J.), motility grant from the Norwegian University of Science and Technology (NTNU) (Å.J.), Sven och Dagmar Saléns stiftelse (Å.J.) and the Swedish Society for Medical Research (Å.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.